BioArctic AB
STO:BIOA B

Watchlist Manager
BioArctic AB Logo
BioArctic AB
STO:BIOA B
Watchlist
Price: 321.2 SEK -0.5% Market Closed
Market Cap: kr28.4B

Profitability Summary

BioArctic AB's profitability score is 83/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

83/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

83/100
Profitability
Score
83/100
Profitability
Score

Margins

Earnings Waterfall
BioArctic AB

Margins Comparison
BioArctic AB Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SE
BioArctic AB
STO:BIOA B
28.4B SEK
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
395.2B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.2B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175.6B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.9B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87.8B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
BioArctic AB Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SE
BioArctic AB
STO:BIOA B
28.4B SEK
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
395.2B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.2B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175.6B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.9B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87.8B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
BioArctic AB

Last Value
3-Years Average
FCF Margin
Conversion Rate